Hormone therapy is widely used to treat menopausal symptoms such as hot flushes and night sweats. But scientists have long debated whether it affects dementia risk.
A new study adds another piece to this puzzle. It suggests that an Alzheimer’s biomarker may help identify which women are more vulnerable to dementia with certain hormone therapies.
